Speake; Jason D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Speake; Jason D..The latest application filed is for "novel oxaborole analogs and uses thereof".
- Speake; Jason D. - Winston-Salem NC
- Speake; Jason D. - Durham NC
- Speake; Jason D - Winston-Salem NC
- Speake; Jason D. - Cary NC
- Speake; Jason D - Durham NC
| Patent | Date |
|---|---|
| Process for the preparation of rucaparib and novel synthesis intermediates Grant 11,220,507 - Beck , et al. January 11, 2 | 2022-01-11 |
| Novel Oxaborole Analogs And Uses Thereof App 20210253605 - Jacobs; Robert Toms ; et al. | 2021-08-19 |
| Oxaborole analogs and uses thereof Grant 10,961,261 - Jacobs , et al. March 30, 2 | 2021-03-30 |
| Process For The Preparation Of Rucaparib And Novel Synthesis Intermediates App 20200331916 - BECK; BRENT CHRISTOPHER ; et al. | 2020-10-22 |
| Single enantiomer antiparasitic compounds Grant 10,807,992 - Speake , et al. October 20, 2 | 2020-10-20 |
| Antiparasitic compounds Grant 10,772,331 - Speake , et al. Sept | 2020-09-15 |
| Chemical Compounds App 20200270257 - Speake; Jason D. ; et al. | 2020-08-27 |
| Sulfonamide derivatives as JAK inhibitors Grant 10,744,136 - Speake , et al. A | 2020-08-18 |
| Synthetic Process and Novel Intermediates App 20200239481 - Speake; Jason D. ; et al. | 2020-07-30 |
| Antiparasitic Compounds App 20200181134 - Speake; Jason D. | 2020-06-11 |
| Chemical Compounds App 20200148693 - SPEAKE; Jason D. ; et al. | 2020-05-14 |
| Chemical Compounds App 20200138811 - SPEAKE; Jason D. ; et al. | 2020-05-07 |
| Substituted ureas as prostaglandin EP4 receptor antagonists Grant 10,570,144 - Speake Feb | 2020-02-25 |
| Synthetic process and intermediates Grant 10,556,909 - Speake , et al. Feb | 2020-02-11 |
| Novel Oxaborole Analogs And Uses Thereof App 20200024289 - Jacobs; Robert Toms ; et al. | 2020-01-23 |
| Substituted Ureas As Prostaglandin Ep4 Receptor Antagonists App 20190382404 - SPEAKE; Jason D. | 2019-12-19 |
| Synthetic Process and Novel Intermediates App 20190284199 - Speake; Jason D ; et al. | 2019-09-19 |
| Antiparasitic Compounds App 20190274305 - Speake; Jason D. ; et al. | 2019-09-12 |
| Antiparasitic compounds Grant 10,342,234 - Speake , et al. July 9, 2 | 2019-07-09 |
| Single Enantiomer Antiparasitic Compounds App 20190152983 - Speake; Jason D. ; et al. | 2019-05-23 |
| Compound 1-[2-[4-(2-ethyl-6,8-dimethylimidazo[1,2-.alpha.]pyrazin-3-yl)phe- nyl]ethyl]-3-(p-tolylsulfonyl)urea as a prostaglandin EP4 receptor antagonist Grant 10,239,885 - Speake | 2019-03-26 |
| Antiparasitic Compounds App 20190000085 - Speake; Jason D. ; et al. | 2019-01-03 |
| Antiparasitic compounds Grant 10,092,001 - Speake , et al. October 9, 2 | 2018-10-09 |
| Antiparasitic Compounds App 20180116223 - SPEAKE; Jason D. ; et al. | 2018-05-03 |
| Antiparasitic compounds Grant 9,883,674 - Speake , et al. February 6, 2 | 2018-02-06 |
| Antiparasitic Compounds App 20170258089 - Speake; Jason D. ; et al. | 2017-09-14 |
| Antiparasitic compounds Grant 9,686,991 - Speake , et al. June 27, 2 | 2017-06-27 |
| Antiparasitic Compounds App 20160324156 - SPEAKE; Jason D. ; et al. | 2016-11-10 |
| Antiparasitic compounds Grant 9,420,793 - Speake August 23, 2 | 2016-08-23 |
| Antiparasitic Compounds App 20160205936 - Speake; Jason D. ; et al. | 2016-07-21 |
| Nicotinic receptor non-competitive antagonists Grant 8,809,397 - Akireddy , et al. August 19, 2 | 2014-08-19 |
| Nicotinic Receptor Non-competitive Antagonists App 20130203860 - Akireddy; Srinivasa Rao ; et al. | 2013-08-08 |
| Substituted Quinazolinone Compounds App 20100105654 - BOYCE; Rustum S. ; et al. | 2010-04-29 |
| Substituted quinazolinone compounds Grant 7,625,909 - Boyce , et al. December 1, 2 | 2009-12-01 |
| Quinazolinone compounds with reduced bioaccumulation Grant 7,368,453 - Boyce , et al. May 6, 2 | 2008-05-06 |
| Pyrimidinones as melanin concentrating hormone receptor 1 Grant 7,285,557 - Carpenter , et al. October 23, 2 | 2007-10-23 |
| Quinazolinone compounds with reduced bioaccumulation App 20050192297 - Boyce, Rustum S. ; et al. | 2005-09-01 |
| Imidazoline derivatives as alpha-1A adrenoceptor ligands Grant 6,884,801 - Bigham , et al. April 26, 2 | 2005-04-26 |
| Substituted quinazolinone compounds App 20050059662 - Boyce, Rustum S. ; et al. | 2005-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 